Verisign ( VRSN) was downgraded at Credit Suisse from outperform to neutral. $42.50 price target. Risk/reward is more balanced at current levels, Credit Suisse said.

Bio-Rad Laboratories ( BIO) target was raised at Jefferies. Shares are now seen reaching $140. Strong fourth-quarter result, Jefferies said. Buy rating.

Darden Restaurants ( DRI) numbers were lowered at Jefferies. Shares are now seen reaching $42. Estimates were also lowered on analyst meeting preannouncement, Jefferies said. Hold rating.

Expeditors International ( EXPD) numbers were lowered at Jefferies. Shares are now seen reaching $44. Estimates were also lowered on earnings miss, Jefferies said. Buy rating.

Home Depot ( HD) numbers were raised at UBS. Shares are now seen reaching $75. Estimates were also increased on strong execution, market share gains and good sector backdrop, UBS said. Buy rating.

Home Depot numbers were raised at Jefferies. Shares are now seen reaching $64. Estimates were also raised on share gains widening in the fourth quarter. Hold rating.

JPMorgan ( JPM) estimates, price target were raised at BofA/Merrill. Shares are now seen reaching $55, according to Bank of America/Merrill Lynch. Estimates were also increased, as the company should see better net interest income and reserve releases, BofA/Merrill said. Buy rating.

Macy's ( M) estimates were raised at UBS. Guidance points to accelerating FCF and expanding ROIC story. Neutral rating.

Priceline.com ( PCLN) estimates, target were boosted at Benchmark. Shares are now seen reaching $800. Estimates were also increased, given accelerating international growth, Benchmark said. Buy rating.

Priceline.com target was raised at Jefferies. Shares are now seen reaching $820. Another solid quarter with some accelerating trends, Jefferies said. Buy rating.

Questcor Pharmaceuticals ( QCOR) numbers were raised at Jefferies. Shares are now seen reaching $38. Estimates were also raised on strong fourth quarter with robust 2013 outlook, Jefferies said. Buy rating.

Vitamin Shoppe ( VSI) numbers were reduced at Credit Suisse. Shares are now seen reaching $65. Estimates were also cut, as the company is facing cost headwinds, Credit Suisse said. Outperform rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.

If you liked this article you might like

Why Alex Rodriguez Is Investing in Billionaires Warren Buffett and Jeff Bezos

Former NY Yankees Slugger Alex Rodriguez Reveals One Juicy Investment Tip

Why I Love Apple, Alphabet, Nvidia and These Other Stocks for September

Have Amazon, Google, Apple and Sony Flooded the Smart Speaker Market?